1-3 of 3
Markus Borner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intense Therapy in Patients with Locally Advanced Esophageal Cancer beyond Hope for Surgical Cure: A Prospective, Multicenter Phase II Trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)

Subject Area:
Oncology
Thomas Ruhstaller, Arnoud Templeton, Karin Ribi, Jan C. Schuller, Markus Borner, Sandra Thierstein, Roger von Moos, Stefanie Pederiva, Andreas Lohri, Norbert Lombriser, Christian von Briel, Dieter Koeberle, Razvan Popescu
Journal: Onkologie
Onkologie (2010) 33 (5): 222–228.
https://doi.org/10.1159/000305094
Published Online: 09 April 2010
View article titled, Intense Therapy in Patients with Locally Advanced Esophageal Cancer beyond Hope for Surgical Cure: A Prospective, Multicenter Phase II Trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)
Open the PDF for Intense Therapy in Patients with Locally Advanced Esophageal Cancer beyond Hope for Surgical Cure: A Prospective, Multicenter Phase II Trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02) in another window
Journal Articles

An Open-Label, Noncomparative Phase II Trial to Evaluate the Efficacy and Safety of Docetaxel in Combination with Gefitinib in Patients with Hormone-Refractory Metastatic Prostate Cancer

Subject Area:
Oncology
Marc Salzberg, Christoph Rochlitz, Rudolf Morant, George Thalmann, Augusto Pedrazzini, Enrico Roggero, Astrid Schönenberger, Alexander Knuth, Markus Borner
Journal: Onkologie
Onkologie (2007) 30 (7): 355–360.
https://doi.org/10.1159/000102452
Published Online: 27 June 2007
View article titled, An Open-Label, Noncomparative Phase II Trial to Evaluate the Efficacy and Safety of Docetaxel in Combination with Gefitinib in Patients with Hormone-Refractory Metastatic Prostate Cancer
Open the PDF for An Open-Label, Noncomparative Phase II Trial to Evaluate the Efficacy and Safety of Docetaxel in Combination with Gefitinib in Patients with Hormone-Refractory Metastatic Prostate Cancer in another window
Journal Articles

Klinische Entwicklung zielgerichteter molekularer Krebstherapeutika

Subject Area:
Oncology
Heinz Zwierzina, Markus Borner
Journal: Onkologie
Onkologie (2005) 28 (Suppl. 4): 35–39.
https://doi.org/10.1159/000088827
Published Online: 03 October 2005
View article titled, Klinische Entwicklung zielgerichteter molekularer Krebstherapeutika
Open the PDF for Klinische Entwicklung zielgerichteter molekularer Krebstherapeutika in another window